Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal abnormalities and oncogenes

K Mitani1

  • 1Third Department of Internal Medicine, University of Tokyo, Japan.

International Journal of Hematology
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients.

International journal of oral and maxillofacial surgery·2020
Same author

Successful glycemic control with three times a week degludec injection by medical staff for an elderly hemodialysis patient with type 2 diabetes.

Diabetology international·2019
Same author

Easy Preparation Method for 2-Thioxopyrrolidine Derivatives Including 3-Hydroxy- methylene-2-thioxopyrrolidine, an Antimicrobial Degradation Product of Radish Pungent Principle, via (E,Z)-4-Ylethoxy-3-butenyl Isothiocyanate.

Bioscience, biotechnology, and biochemistry·2016
Same author

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma.

Blood cancer journal·2015
Same author

BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector.

Gene therapy·2015
Same author

Size distribution of total and water-soluble fractions of particle-bound elements-assessment of possible risks via inhalation.

Environmental science and pollution research international·2015

Chromosomal translocations alter transcription factors, driving leukemia and lymphoma. A specific fusion gene, AML1/EVI-1, identified in chronic myeloid leukemia, blocks differentiation and stimulates proliferation, offering new insights into leukemogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chromosomal translocations involving transcription factor genes are key drivers of leukemogenesis and lymphomagenesis.
  • These alterations manifest as either chimeric gene formation or aberrant gene expression without structural changes.
  • Examples include AML1/MTG8 in t(8;21) and PML/RAR alpha in t(15;17) in acute myeloid leukemia.

Purpose of the Study:

  • To investigate the role of transcription factor gene alterations in cancer development.
  • To characterize the AML1/EVI-1 fusion gene resulting from the t(3;21) translocation.
  • To elucidate the molecular mechanisms underlying leukemogenesis driven by chimeric transcription factors.

Main Methods:

  • Classification of transcription factor gene alterations based on chromosomal translocations.

Related Experiment Videos

  • Isolation and characterization of the AML1/EVI-1 fusion gene.
  • Analysis of the functional impact of the chimeric transcription factor.

    • Main Results:

    • Identified two main types of alterations: chimeric gene formation and aberrant expression.
    • The AML1/EVI-1 fusion gene, found in blastic crisis of chronic myeloid leukemia, was isolated.
    • The resulting chimeric transcription factor exhibits dual functions: blocking differentiation and stimulating proliferation.

    Conclusions:

    • Chimeric transcription factors play a critical role in the development of leukemia.
    • The AML1/EVI-1 fusion gene provides a specific example of a chimeric transcription factor with oncogenic functions.
    • These findings enhance the understanding of the molecular mechanisms in leukemogenesis.